Serum Creatinine and Estimated GFR Predict Long-Term Efficacy of Vasopressin Receptor Antagonist in Patients with Decompensated Heart Failure

被引：0
|
作者：
Tsukamoto, Shigeto [1 ]
Syouji, Makoto [1 ]
Koba, Shinji [1 ]
Kobayashi, Youichi [1 ]
机构：
[1] Showa Univ, Sch Med, Div Cardiol, Dept Med, Tokyo, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2016年 / 22卷 / 09期
关键词：
D O I：
10.1016/j.cardfail.2016.07.238
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP1-2
引用
收藏
页码：S197 / S197
页数：1
相关论文
共 50 条
  • [1] Serum Creatinine and Estimated GFR Predict Long-term Efficacy of Vasopressin Receptor Antagonist in Patients with Decompensated Heart Failure
    Tsukamoto, Shigeto
    Sakai, Tetsuo
    Sekimoto, Teruo
    Adachi, Taro
    Hamazaki, Yuji
    Kobayashi, Youichi
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S174 - S174
  • [2] Efficacy of Additional Administration of Vasopressin Receptor Antagonist in Acute Decompensated Heart Failure: A Prospective Randomized Study
    Sakai, Tetsuo
    Kanako, Gyouiti
    Tsukamoto, Shigeto
    Shoji, Makoto
    Kobayashi, Youichi
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : S204 - S204
  • [3] Additive effect of increased urea and creatinine levels at admission on long-term prognosis in patients with decompensated heart failure
    Maris Macin, Stella
    Perna, Eduardo R.
    Cimbaro Canella, Juan Pablo
    Coronel, Lorena M.
    Franciosi, Valeria
    Szyszko, Ariel
    Kriskovich, Jorge O. J.
    Bayol, Pablo A.
    Vargas Morales, Walter
    INSUFICIENCIA CARDIACA, 2006, 1 (02) : 78 - 83
  • [4] Serum albumin to creatinine ratio as predictor for long-term mortality in patients with acute heart failure
    Murat, Selda
    Altinbas, Mehmet Eren
    Yalvac, Halit Emre
    Durmaz, Fatih Enes
    Murat, Bektas
    Cavusoglu, Yuksel
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2022, 26 : S45 - S46
  • [5] Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Jhund, Pardeep
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Shah, Sanjiv J.
    Desai, Akshay S.
    Lindholm, Daniel
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (19) : 1775 - 1784
  • [6] Effects of the vasopressin V2 receptor antagonist, tolvaptan, on the long-term progression of left ventricular dilatation in patients with heart failure
    Udelson, JE
    Mcgrew, F
    Flores, E
    Ibrahim, H
    Koshkarian, G
    Katz, S
    O'Brien, T
    Zimmer, C
    Konstam, MA
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : 720 - 720
  • [7] Effects of the vasopressin V2 receptor antagonist, tolvaptan, on the long-term progression of left ventricular dilatation in patients with heart failure
    Udelson, JE
    McGrew, F
    Flores, E
    Ibrahim, H
    Koshkarian, G
    Katz, S
    O'Brien, T
    Johnson, RH
    Zimmer, C
    Orlandi, C
    Konstam, MA
    CIRCULATION, 2005, 112 (17) : U564 - U564
  • [8] Admission glucose did not predict long-term outcomes in patients admitted with advanced decompensated heart failure (ADHF)
    Sokos, George G.
    Mullens, Wilfried
    Abrahams, Zuheir
    Taylor, David O.
    Starling, Randall C.
    Tang, W. H. Wilson
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) : S96 - S97
  • [9] Residual congestion and long-term prognosis in acutely decompensated heart failure patients
    E. Ceriani
    G. Casazza
    J. Peta
    D. Torzillo
    S. Furlotti
    C. Cogliati
    Internal and Emergency Medicine, 2020, 15 : 719 - 724
  • [10] Residual congestion and long-term prognosis in acutely decompensated heart failure patients
    Ceriani, E.
    Casazza, G.
    Peta, J.
    Torzillo, D.
    Furlotti, S.
    Cogliati, C.
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (04) : 719 - 724
12345